PPARG and cancer: PPARγ affects inflammation directly, bydriving CD36-dependent apoptosis in MΦs [62, 63], or indirectly, by reducing VCAM-1expression by the ECs and thus blocking transendothelial migration (TEM) ofmonocytes and MΦs during chronic inflammation typicalfor diabetes and cancer.